In the future, further studies with large sample size and pedigree samples are needed to verify the conclusions obtained in this study and gain a thorough understanding on the molecular mechanism of TPO mutation involved in the CH pathogenesis. The gene discussed is TPO; the disease is cyclic hematopoiesis.